Fatigue relief drug's heart hope
305645
An experimental drug developed to relieve fatigue after exercise may also help heart failure patients.
766518
A study shows promising results for Novartis's COX-2 inhibitor.
409638
Promising trials for a hepatitis C treatment bode well for the pharmaceutical.
489869
A molecule that promotes the growth of the young heart shows promise as a treatment for heart attack in animal studies and is being readied for human trials, researchers report.
723523
A long-acting niacin drug that  raises so-called good cholesterol showed promise in slowing the  clogging of arteries when taken along with cholesterol-lowering  statins compared to statin therapy alone, according to a small  clinical study.
10877
WEDNESDAY, Feb. 13 (HealthDay News) -- A greater percentage of patients than previously thought may develop heart failure when taking the breakthrough cancer drug Sutent, researchers report.
377388
A way to measure energy levels inside living heart cells could ultimately aid heart attack recovery.
372129
A successful cancer-fighting drug may also damage the heart, although a researcher says leukemia patients who need Gleevec should not abandon it.
320147
Cancer drug shows exceptional promise as it moves toward FDA review.
606467
Alpharetta-based AtheroGenics announced positive interim results Monday from a clinical trial of its drug to treat atherosclerosis, which leads to coronary heart disease.
598998
NEW YORK  - A protein powder that mixes amino acids, vitamins and minerals may help beat fatigue during intense exercise, a small study suggests.
548970
A drug widely used to treat H.I.V. infection may also be effective in fighting cancer, a new study suggests, and a human trial of the medicine is already under way.
87010
New data are due out on a promising cholesterol drug. But there are doubters.
403138
NEW ORLEANS - An experimental pill that offers the promise of helping people lose weight and quit smoking has raised more expectations.
449009
A new type of drug shows growing promise as a more potent way for many breast-cancer patients to significantly cut their risk of recurrence, researchers reported yesterday.
725261
There's encouraging news about an enzyme replacement drug.
646040
A heart treatment from Canadian   biotech firm Vasogen Inc., which failed a key clinical trial   hurdle in June, still helped more than 70 percent of patients,   researchers said on Sunday.